Bahadır DEMİR, Esra GUNEYSU, Muhammet SANCAKTAR, Şengül KOCAMER ŞAHİN, Gülçin ELBOĞA, Abdurrahman ALTINDAĞ

Effect of the COVID-19 pandemic on medication adherence in psychiatric disorders

The aim of this study is to investigate the effect of COVID-19 pandemic and the restrictions taken on the medication, thus treatment adherence of patients with psychiatric disorders. A semi-structured form prepared by the authors and the Morisky treatment adherence scale were applied to the patients who were regularly followed up in Gaziantep University Medical Faculty Psychiatry outpatient clinic for 6 months before March 11, 2020, which was the first date of the COVID-19 case in Turkey and who visited the outpatient clinic for follow-up after the pandemic. 206 patients who met the study criteria were evaluated. Of these patients, it was found that 29 (14.1%) had their medication adherence impaired due to non-pandemic reasons. Analysis was performed with the remaining 177 patients. The average age of patients was 41.73 ± 13.48. According to the general characteristics of the participants, 117 were women and 60 men. With regard to the treatment adherence rates, 69 patients (39%) were not affected by the pandemic in which treatment adherence was high, 46 (26%) had moderate treatment adherence, and 62 (35%) showed poor treatment adherence. The comparison of patients in terms of treatment adherence according to their diagnosis revealed no statistically significant difference (p = 0.100). To the best of our knowledge, this is the first study investigating the medication (treatment) adherence of patients with psychiatric disorders who were on treatment before the pandemic. Studies with large samples are warranted to better understand the effect of the pandemic on treatment adherence.

PDF

___

Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531-42.

Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912-20.

Chen A. Noncompliance in community psychiatry: a review of clinical interventions. Psychiatric Services. 1991;42:282-7.

Cobanoğlu ZSU, Aker T, Cobanoglu N. Treatment adherence problems in patients with schizophrenia and other psychotic disorders. Dusunen Adam J Psychiatry Neurol Science. 2003;16:211-8.

Ervatan SO, Ozel A, Turkcapar H, et al. Compliance to Treatment in Depressive Patients: A Naturalistic Follow-up Study. J Clin Psy. 2003;6:5- 11.

Swartz MS, Swanson JW, Hannon MJ. Does fear of coercion keep people away from mental health treatment? Evidence from a survey of persons with schizophrenia and mental health professionals. Behavioral sciences & the law. 2003;21:459-72.

Perkins DO. Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry. 2002;63:1121-8.

Kampman O, Laippala P, Väänänen J, et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002;110:39-48.

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986:67- 74.

Bahar G, Savas HA, Unal A, et al. Reliability and validity of the Morisky Medication Adherence Scale for bipolar mood disorder. Anatolian J Psychiatry. 2014;15: 141-9.

Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatric Clin North Am. 2007;30:437-52.

Masand PS, Roca M, Turner MS, et al. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry. 2009;11:147.

Alpak G, Aksoy I, Demir B, et al. Missed appointments and medication noncompliance among consecutive psychiatric patients. Psychiatry Behavioral Sci. 2015;5:151.

Mitchell AJ, Selmes T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Advances Psychiatric Treatment. 2007;13:336-46.

Holmes EA, O'Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020.

Yang Y, Li W, Zhang Q, et al. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020;7:e19.

Thome J, Deloyer J, Coogan AN, et al. The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe. World J Biol Psychiatry. 2020:1-10.

Ates M, Algul A. Medication non-adherence in bipolar disorders. Turkiye Klinikleri J Int Med Sci. 2006;2:60-4.

Demirkol M, Tamam L, Evlice Y, et al. Adherence to the treatment in psychiatric patients. Cukurova Med J. 2015;40:555-68.

Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services. 2000;51:216-22.